Sharing is caring: a network collaborative approach to identify and address barriers in accessing clinical trials in adolescents and young adults with leukemia and lymphoma

2.

Cheson

BD

,

Fisher

RI

,

Barrington

SF

, et al;

Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/Dutch Hemato-Oncology Group; Grupo Español de Médula Ósea; German High-Grade Lymphoma Study Group; German Hodgkin's Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute

.

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

.

J Clin Oncol

.

2014

;

32

(

27

):

3059

-

3068

.

3.

Flerlage

JE

,

Kelly

KM

,

Beishuizen

A

, et al.

Staging evaluation and response criteria harmonization (SEARCH) for childhood, adolescent and young adult Hodgkin lymphoma (CAYAHL): methodology statement

.

Pediatr Blood Cancer

.

2017

;

64

:

e26421

.

4.

Kahn

JM

,

Pei

Q

,

Friedman

DL

, et al.

Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials

.

Lancet Haematol

.

2022

;

9

(

1

):

e49

-

e57

.

5.

Herrera

AF

,

LeBlanc

ML

,

Castellino

SM

, et al.

SWOG S1826, a randomized study of nivolumab (N)-AVD versus brentuximab vedotin (BV)-AVD in advanced stage (AS) classic Hodgkin lymphoma (HL)

.

J Clin Oncol

.

2023

;

41

(

17_suppl

):

lba4

.

6.

Stock

W

,

Luger

SM

,

Advani

AS

, et al.

A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

.

Blood

.

2019

;

133

(

14

):

1548

-

1559

.

7.

Gupta

S

,

Wang

C

,

Raetz

EA

, et al.

Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group

.

J Clin Oncol

.

2020

;

38

(

17

):

1897

-

1905

.

8.

Advani

AS

,

Larsen

E

,

Laumann

K

, et al.

Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia

.

Blood Adv

.

2021

;

5

(

2

):

504

-

512

.

9.

Toner

K

,

Allen

CE

,

Jain

S

, et al.

Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphoma

.

EJHaem

.

2023

;

4

(

4

):

921

-

926

.

. https://www.gao.gov/products/gao-23-105947,

10.

Pediatric Cancer Studies: early results of the research to accelerate cures and equity for children act

January

31

,

2023

.

11.

Freyer

DR

,

Seibel

NL

.

The clinical trials gap for adolescents and young adults with cancer: recent progress and conceptual framework for continued research

.

Curr Pediatr Rep

.

2015

;

3

(

2

):

137

-

145

.

12.

Ferrari

A

,

Stark

D

,

Peccatori

FA

, et al.

Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)

.

ESMO Open

.

2021

;

6

(

2

):

100096

.

13.

Barakat

LP

,

Schwartz

LA

,

Reilly

A

,

Deatrick

JA

,

Balis

F.

A qualitative study of phase III cancer clinical trial enrollment decision-making: perspectives from adolescents, young adults, caregivers, and providers

.

J Adolesc Young Adult Oncol

.

2014

;

3

(

1

):

3

-

11

.

14.

Thomas

SM

,

Malvar

J

,

Tran

HH

,

Shows

JT

,

Freyer

DR

.

A prospective comparison of cancer clinical trial availability and enrollment among adolescents/young adults treated at an adult cancer hospital or affiliated children's hospital

.

Cancer

.

2018

;

124

(

20

):

4064

-

4071

.

15.

Downs-Canner

S

,

Shaw

PH

.

A comparison of clinical trial enrollment between adolescent and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers

.

J Pediatr Hematol Oncol

.

2009

;

31

(

12

):

927

-

929

.

16.

Shaw

PH

,

Hayes-Lattin

B

,

Johnson

R

,

Bleyer

A.

Improving enrollment in clinical trials for adolescents with cancer

.

Pediatrics

.

2014

;

133

(

suppl 3

):

S109

-

S113

.

17.

Marshall

CS

,

Grimes

A.

Pediatric physician management as a predictor of clinical trial enrollment in adolescent and young adult cancer patients

.

J Adolesc Young Adult Oncol

.

2020

;

9

(

2

):

183

-

189

.

18.

Siembida

EJ

,

Loomans-Kropp

HA

,

Tami-Maury

I

, et al.

Barriers and facilitators to adolescent and young adult cancer trial enrollment: NCORP site perspectives

.

JNCI Cancer Spectr

.

2021

;

5

(

3

):

pkab027

.

19.

Roth

M

,

Mittal

N

,

Saha

A

,

Freyer

DR

.

The children's oncology group adolescent and young adult responsible investigator network: a new model for addressing site-level factors impacting clinical trial enrollment

.

J Adolesc Young Adult Oncol

.

2020

;

9

(

4

):

522

-

527

.

20.

Mittal

N

,

Saha

A

,

Avutu

V

,

Monga

V

,

Freyer

DR

,

Roth

M.

Shared barriers and facilitators to enrollment of adolescents and young adults on cancer clinical trials

.

Sci Rep

.

2022

;

12

(

1

):

3875

.

21.

Mora

V

,

Colantuono

S

,

Fanali

C

, et al;

SC&RN group

.

Clinical research coordinators: key components of an efficient clinical trial unit

.

Contemp Clin Trials Commun

.

2023

;

32

:

101057

.

22.

Vanhoff

D

,

Hesser

T

,

Kelly

KP

,

Freyer

D

,

Stork

S

,

Sung

L.

Facilitating accrual to cancer control and supportive care trials: the clinical research associate perspective

.

BMC Med Res Methodol

.

2013

;

13

:

154

.

23.

Osborn

M

,

Johnson

R

,

Thompson

K

, et al.

Models of care for adolescent and young adult cancer programs

.

Pediatr Blood Cancer

.

2019

;

66

(

12

):

e27991

.

24.

Haines

E

,

Asad

S

,

Lux

L

, et al.

Guidance to support the implementation of specialized adolescent and young adult cancer care: a qualitative analysis of cancer programs

.

JCO Oncol Pract

.

2022

;

18

(

9

):

e1513

-

e1521

.

25.

St Germain

DC

,

McCaskill-Stevens

W.

Use of a clinical trial screening tool to enhance patient accrual

.

Cancer

.

2021

;

127

(

10

):

1630

-

1637

.

26.

Shaw

PH

,

Boyiadzis

M

,

Tawbi

H

, et al.

Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions

.

Cancer

.

2012

;

118

(

14

):

3614

-

3617

.

27.

Hesko

C

,

Mittal

N

,

Avutu

V

,

Thomas

S-M

,

Heath

J-L

,

Roth

M-E

.

Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative)

.

Curr Probl Cancer

.

2023

;

47

(

6

):

100898

.

28.

Sankaran

H

,

Finnigan

SR

,

McShane

LM

,

Best

AF

,

Seibel

NL

.

Enrollment of adolescent and young adult patients newly diagnosed with cancer in NCI CTEP-sponsored clinical trials before and after launch of the NCI National Clinical Trials Network

.

Cancer

.

2022

;

128

(

21

):

3843

-

3849

.

29.

Keegan

THM

,

Parsons

HM

.

Adolescent angst: enrollment on clinical trials

.

Hematology Am Soc Hematol Educ Program

.

2018

;

2018

(

1

):

154

-

160

.

30.

de Rojas

T

,

Neven

A

,

Terada

M

, et al.

Access to clinical trials for adolescents and young adults with cancer: a meta-research analysis

.

JNCI Cancer Spectr

.

2019

;

3

(

4

):

pkz057

.

31.

Mittal

N

,

Langevin

A-M

,

Kyono

W

, et al.

Barriers to pediatric oncologist enrollment of adolescents and young adults on a cross-network National Clinical Trials Network supportive care cancer clinical trial

.

J Adolesc Young Adult Oncol

.

2022

;

11

(

1

):

117

-

121

.

32.

Dickens

DS

,

Roth

ME

,

Pollock

BH

,

Langevin

A-M

.

Understanding the barriers to pediatric oncologist engagement and accrual to clinical trials in National Cancer Institute-designated community oncology research programs

.

JCO Oncol Pract

.

2020

;

16

(

10

):

e1060

-

e1066

.

33.

Hamm

C

,

Cavallo-Medved

D

,

Moudgil

D

, et al.

Addressing the barriers to clinical trials accrual in community cancer centres using a national clinical trials navigator: a cross-sectional analysis

.

Cancer Control

.

2022

;

29

:10732748221130164.

34.

Clark

LT

,

Watkins

L

,

Piña

IL

, et al.

Increasing diversity in clinical trials: overcoming critical barriers

.

Curr Probl Cardiol

.

2019

;

44

(

5

):

148

-

172

.

35.

Ellis

JA

,

Malalasekera

VS

,

Allan

C

, et al.

Systems-level change to alleviate barriers to cancer clinical trial access for adolescents and young adults in Australia

.

J Adolesc Young Adult Oncol

.

2022

;

11

(

2

):

173

-

180

.

36.

Knudsen

KE

,

Wiatrek

DE

,

Greenwald

J

,

McComb

K

,

Sharpe

K.

The American Cancer Society and patient navigation: past and future perspectives

.

Cancer

.

2022

;

128

(

suppl 13

):

2673

-

2677

.

37.

Kline

RM

,

Rocque

GB

,

Rohan

EA

, et al.

Patient navigation in cancer: the business case to support clinical needs

.

J Oncol Pract

.

2019

;

15

(

11

):

585

-

590

.

38.

Thurston

C

,

Deleemans

JM

,

Gisser

J

,

Piercell

E

,

Ramasamy

V

,

Tutelman

PR

.

The development and impact of AYA Can—Canadian cancer advocacy: a peer-led advocacy organization for adolescent and young adult cancer in Canada

.

Curr Oncol

.

2024

;

31

(

5

):

2582

-

2588

.

39.

Ciccarella

A

,

Staley

AC

,

Franco

AT

.

Transforming research: engaging patient advocates at all stages of cancer research

.

Ann Transl Med

.

2018

;

6

(

9

):

167

.

40.

Mobley

EM

,

Swami

U

,

Mott

S

,

Ounda

A

,

Milhem

M

,

Monga

V.

A retrospective analysis of clinical trial accrual of patients presented in a multidisciplinary tumor board at a tertiary health care center and associated barriers

.

Oncol Res Treat

.

2020

;

43

:

196

-

203

.

41.

Williams

E

,

Brown

TJ

,

Griffith

P

, et al.

Improving the time to activation of new clinical trials at a National Cancer Institute-designated comprehensive cancer center

.

JCO Oncol Pract

.

2020

;

16

:

e324

-

e332

.

42.

Wong

AR

,

Sun

V

,

George

K

, et al.

Barriers to participation in therapeutic clinical trials as perceived by community oncologists

.

JCO Oncol Pract

.

2020

;

16

:

e849

-

e858

.

43.

Higgins

KA

,

Thomas

A

,

Soto

N

, et al.

Creating and implementing a principal investigator tool kit for enhancing accrual to late phase clinical trials: development and usability study

.

JMIR Cancer

.

2022

;

8

:

e38514

.

44.

Thomas

EE

,

Kelly

JT

,

Taylor

ML

, et al.

Telehealth adoption in cancer clinical trials: an Australian perspective

.

Asia Pac J Clin Oncol

.

2023

;

19

:

549

-

558

.

45.

Avutu

V

,

Monga

V

,

Mittal

N

, et al.

Use of communication technology to improve clinical trial participation in adolescents and young adults with cancer: Consensus statement from the Children’s Oncology Group Adolescent and Young Adult Responsible Investigator Network

.

JCO Oncol Pract

.

2022

;

18

:

224

-

231

.

46.

Cowdery

JE

,

Powell

JH

,

Fleming

YA

,

Brown

DL

.

Effectiveness of a short video- based educational intervention on factors related to clinical trial participation in adolescents and young adults: a pre-test/post-test design

.

Trials

.

2019

;

20

:

7

.

47.

Pannier

ST

,

Warner

EL

,

Fowler

B

,

Fair

D

,

Salmon

SK

,

Kirchhoff

AC

.

Age- specific patient navigation preferences among adolescents and young adults with cancer

.

J Cancer Educ

.

2019

;

34

:

242

-

251

.

48.

Wolfson

JA

,

Grimes

AC

,

Nuno

M

, et al.

Characteristics of health care settings where adolescents and young adults receive care for ALL

.

JCO Oncol Pract

.

2024

;

20

:

491

-

502

.